IBL Tool - Digitale Bibliotheek

Digitale Bibliotheek

Sluiten

Tijdschrift beschrijving

Alle jaargangen van het bijbehorende tijdschrift

Alle afleveringen van het bijbehorende jaargang

Alle artikelen van de bijbehorende aflevering

32 gevonden resultaten

nr	titel	auteur	tijdschrift	jaar	jaarg.	afl.	pagina('s)	type
1	AAP policy statements on smallpox vaccine and sedation of children			2002	388	1	p. 2	artikel
2	AAP policy statements on smallpox vaccine and sedation of children				388	1	p. 2	artikel
3	ACE inhibitor prescribing after MI appropriate in Australia			2002	388	1	p. 7	artikel
4	Atopic dermatitis imposes large financial, QOL burden			2002	388	1	p. 10	artikel
5	Azithromycin cost saving for CAP in the US			2002	388	1	p. 7	artikel
6	Better guidance needed for multinational economic evaluations			2002	388	1	p. 2	artikel
7	Cost of atopic dermatitis low in The Netherlands			2002	388	1	p. 8	artikel
8	Direct-to-consumer drug advertising rejected in the EU			2002	388	1	p. 11	artikel
9	Duloxetine new hope for Eli Lilly in depression market			2002	388	1	p. 12	artikel
10	Enoxaparin sodium more effective, less costly than UFH			2002	388	1	p. 6	artikel
11	ESRD costs and burden reduced with losartan in the EU			2002	388	1	p. 3-4	artikel
12	EU pharma law undergoes major reforms			2002	388	1	p. 11	artikel
13	Frequent deviation from ACE inhibitor guidelines in France			2002	388	1	p. 9	artikel
14	GlaxoSmithKline fields AIDS group lawsuit			2002	388	1	p. 11	artikel
15	HAART improves hospitalisation characteristics in HIV infection			2002	388	1	p. 7	artikel
16	Hepatitis B vaccine market falters in India			2002	388	1	p. 12	artikel
17	ICD cost effective in patients at high risk for sudden cardiac death			2002	388	1	p. 6	artikel
18	India's TB control programme `remarkably successful'			2002	388	1	p. 7	artikel
19	Infliximab plus methotrexate cost effective in RA			2002	388	1	p. 5	artikel
20	Lamivudine warranted for hepatitis B in Poland			2002	388	1	p. 9	artikel
21	MIDAS QOL tool `highly reliable' for MI			2002	388	1	p. 10	artikel
22	Neonatal screening for metabolic disorders warranted in the US			2002	388	1	p. 8	artikel
23	Optimising clinical guideline use in clinical practice			2002	388	1	p. 4	artikel
24	Paroxetine improves QOL in premenstrual dysphoric disorder			2002	388	1	p. 10	artikel
25	Quality of antihypertensive therapy improved with guideline intervention			2002	388	1	p. 5	artikel
26	Remifentanil cost saving vs fentanyl in CABG surgery?			2002	388	1	p. 5	artikel
27	SLI-381 improves symptoms, QOL in ADHD			2002	388	1	p. 10	artikel
28	Tolterodine less costly than oxybutynin in overactive bladder			2002	388	1	p. 8	artikel
29	UK NICE releases guidance on thrombolytic use in MI			2002	388	1	p. 2	artikel
30	Urinary incontinence market to reach $US2.5 billion in 2011			2002	388	1	p. 11	artikel
31	VTE after orthopaedic surgery increases LOS, costs			2002	388	1	p. 9	artikel
32	Years of healthy life can be increased 5-10 years, says WHO report			2002	388	1	p. 6	artikel

32 gevonden resultaten

Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland